The Effect of Salpingectomy Operation on Ovarian Reserve

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

31 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-10-27

Study Completion Date

2021-06-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to evaluate the effect of salpingectomy operation on ovarian reserve. Ovarian reserve was evaluated by measuring anti-mullerian hormone levels from serum samples taken from the patients before the operation and 6 weeks after the operation. Ovarian doppler flow were evaluated by measuring the ovarian artery pulsatility index with transvaginal ultrasonography preoperatively, postoperative days 2 and postoperative weeks 6 . In our study, it was determined that ovarian functions may be negatively affected in the acute period after salpingectomy operation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Does Vnotes Salpingectomy Reduce Ovarian Reserve?

NCT07177144

Vnotes Salpingectomy Ovarian Reserve

COMPLETED NA

Residual Tubal Tissue on the Ovarian Surface Following Salpingectomy With Laparoscopy and Laparotomy

NCT03322605

Salpingectomy

UNKNOWN

Anti-Mullerian Hormone (AMH) is a Marker for Ovarian Reserve. There Are Many Studies About AMH Changes in Ovarian Surgery, But Little is Known for Other Surgeries. We Seek to Investigate the Hormone Variations Before and After Uterine Artey Ligation for Postpartum Hemorrage (PPH)

NCT03907605

Anti-Mullerian Hormone Deficiency Post Partum Hemorrhage

COMPLETED

Bilateral Oophorectomy Versus Ovarian Conservation

NCT01007305

Oophorectomy Hysterectomy

COMPLETED NA

Evaluation of the Ovarian Reserve in Patients Who Hypogastric Arteries and or Uterine Arteries Had Been Ligated

NCT02995343

Ovarian Reserve Hypogastric Artery Ligation Uterine Artery Ligation

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ovarian Insufficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

perioperative ovarian arter pulsatility index(PI)(right and left), perioperative AMH levels

bilateral salpingectomy, ovarian arter doppler ultrasonography

Intervention Type PROCEDURE

The effect of salpingectomy operation on ovarian reserve

postoperative days 2 ovarian arter pulsatility index (PI) (right and left)

bilateral salpingectomy, ovarian arter doppler ultrasonography

Intervention Type PROCEDURE

The effect of salpingectomy operation on ovarian reserve

postop. weeks 6 ovarian arter pulsatility index(PI)(right and left), postop. weeks 6 AMH levels

bilateral salpingectomy, ovarian arter doppler ultrasonography

Intervention Type PROCEDURE

The effect of salpingectomy operation on ovarian reserve

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bilateral salpingectomy, ovarian arter doppler ultrasonography

The effect of salpingectomy operation on ovarian reserve

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Women between the ages of 37-45 with continuing menstrual cycles (37 and 45 included)
2. Patients who will undergo uterine surgery for benign reasons or who will undergo salpingectomy only due to hydrosalpinx, ectopic pregnancy, tubo-ovarian abscess
3. Patients who have not had ovarian surgery before
4. Those without menopause and premature ovarian failure
5. Patients who accept the study

Exclusion Criteria

1. Age younger than 37 or older than 45
2. Those who want to withdraw from the study
3. Those who do not come for follow-up examination
4. Use of drugs that affect ovarian reserve
5. Any surgical procedure performed on the ovaries during the operation
6. No menstrual bleeding in the last year
7. Patients who received radiotherapy and hormonal therapy within 3 months before surgery

Minimum Eligible Age

37 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes